Increasing the genome-targeting scope and precision of base editing with engineered Cas9-cytidine deaminase fusions.
| Authors | |
| Abstract | Base editing induces single-nucleotide changes in the DNA of living cells using a fusion protein containing a catalytically defective Streptococcus pyogenes Cas9, a cytidine deaminase, and an inhibitor of base excision repair. This genome editing approach has the advantage that it does not require formation of double-stranded DNA breaks or provision of a donor DNA template. Here we report the development of five C to T (or G to A) base editors that use natural and engineered Cas9 variants with different protospacer-adjacent motif (PAM) specificities to expand the number of sites that can be targeted by base editing 2.5-fold. Additionally, we engineered base editors containing mutated cytidine deaminase domains that narrow the width of the editing window from ∼5 nucleotides to as little as 1-2 nucleotides. We thereby enabled discrimination of neighboring C nucleotides, which would otherwise be edited with similar efficiency, and doubled the number of disease-associated target Cs able to be corrected preferentially over nearby non-target Cs. |
| Year of Publication | 2017
|
| Journal | Nat Biotechnol
|
| Volume | 35
|
| Issue | 4
|
| Pages | 371-376
|
| Date Published | 2017 Apr
|
| ISSN | 1546-1696
|
| DOI | 10.1038/nbt.3803
|
| PubMed ID | 28191901
|
| PubMed Central ID | PMC5388574
|
| Links | |
| Grant list | Howard Hughes Medical Institute / United States
R01 EB022376 / EB / NIBIB NIH HHS / United States
R35 GM118062 / GM / NIGMS NIH HHS / United States
|